Academic research

March 30, 2021
AIMS, Academic Research

Since the 2003 discovery that the PCSK9 protein played a key role in regulating metabolism of low-density lipoprotein (LDL), pharmaceutical companies have poured resources into targeting it for cholesterol management. There has been some success […]

Read Article
February 17, 2021
AIMS, Academic Research, Joint Ventures

Long before SARS-CoV-2 triggered the worst pandemic most of us have ever experienced, Nito Panganiban was concerned about the ability of RNA viruses to leap from animal reservoirs into the human population. In the past century, there have been more […]

Read Article
January 22, 2021
AIMS, Academic Research

While outcomes for breast cancer patients have steadily improved over the years, one particularly vexing type known as triple-negative breast cancer (TNBC) has continued to defy those rosy trends. One of the challenges in treating TNBC is that it […]

Read Article
November 04, 2020
AIMS, Academic Research

Jeffrey MacKeigan is not your traditional academic scientist. After completing his postdoctoral fellowship, he spent two years at one of the largest pharmaceutical companies in the world. That gives him a unique perspective on how academic labs, […]

Read Article
October 28, 2020
AIMS, Academic Research, Featured

It’s not unusual for scientists to be discouraged by a lack of treatment options for their disease of interest. There is, however, a special kind of frustration for researchers who have clearly identified a promising biological target for treating […]

Read Article
September 15, 2020
AIMS, Academic Research, AI Drug Discovery

With the implementation of genomic technologies, medicine is becoming increasingly personalized thanks to new treatments that target important molecular targets. In the context of Parkinson's disease, there is an urgent need to identify molecular […]

Read Article
August 14, 2020
AIMS, Academic Research

Ron Viola, a Distinguished University Professor at the University of Toledo, still remembers the moment he realized how sorely needed his research on the rare Canavan disease would be. He had just been awarded an NIH grant when the mother of a […]

Read Article
August 06, 2020
AIMS, Academic Research

Young Tang was on the road to becoming a physician when he realized that research was his real calling. During his medical training, as various professors taught him about the wide range of diseases and treatment regimens, what struck him most was […]

Read Article
July 14, 2020
AIMS, Academic Research, Joint Ventures

There is no treatment for the most common form of age-related macular degeneration, the leading cause of blindness in the developed world. But thanks to a fruitful collaboration between Professor Jeff Perry at the University of California, […]

Read Article
Pages: 1 2 »

Subscribe

Stay up to date on new blog posts.

Atomwise needs the contact information you provide to send you updates. You may unsubscribe from these communications at any time. For information please review our Privacy Policy.